EXPAREL 13.3 mg/mL
bupivacaine · INJECTION, SUSPENSION, LIPOSOMAL · Pacira Pharmaceuticals, Inc.
EXPAREL is a injection, suspension, liposomal containing bupivacaine at 13.3 mg/mL, taken infiltration. Manufactured by Pacira Pharmaceuticals, Inc..
Key Facts
- Brand Name
- EXPAREL
- Generic Name
- bupivacaine
- NDC Code (Product)
65250-266- Manufacturer
- Pacira Pharmaceuticals, Inc.
- Strength
- 13.3 mg/mL
- Dosage Form
- INJECTION, SUSPENSION, LIPOSOMAL
- Route
- INFILTRATION
- Marketing Status
- Application #
- NDA022496
- Drug Class
- Amide Local Anesthetic [EPC]
- Marketing Start
- 01/01/2012
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is EXPAREL used for?
EXPAREL contains bupivacaine. It is a injection, suspension, liposomal taken infiltration. Consult your doctor for specific uses.
Is EXPAREL a controlled substance?
EXPAREL is not classified as a controlled substance by the DEA.
What is the generic name for EXPAREL?
The generic name for EXPAREL is bupivacaine. There are 12 other brand versions of bupivacaine.
What is the NDC code for EXPAREL 13.3 mg/mL?
The NDC (National Drug Code) for EXPAREL 13.3 mg/mL is 65250-266, listed by Pacira Pharmaceuticals, Inc..
Other Bupivacaine Brands
See all →- Bupivacaine Hydrochloride2.5 mg/mL85766-074
- Bupivacaine Hydrochloride7.5 mg/mL0143-9332
- Bupivacaine Hydrochloride2.5 mg/mL55150-167
- Bupivacaine13.3 mg/mL57884-3252
- Bupivacaine Hydrochloride5 mg/mL0409-1163
- Marcaine150 mg/30mL0409-1530
- Marcaine with Epinephrine5 mg/mL0409-1749
- Marcaine with Epinephrine5 mg/mL0409-4208
- Marcaine with Epinephrine2.5 mg/mL0409-5738
- Marcaine with Epinephrine5 mg/mL0409-6581
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)